Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph A Defronzo

Showing results (21-30 of 313) with videos related to

Pageof 32
Sort By:
Diabetes Spectrum : a Publication of the American Diabetes Association|September 13, 2021
Sodium-Glucose Cotransporter 2 Inhibitors and the KidneyRalph A DeFronzo, Muhammad Abdul-Ghani
Current Pharmaceutical Biotechnology|December 24, 2015
Beta Cell Formation in vivo Through Cellular Networking, Integration and Processing (CNIP) in Wild Type Adult MiceBruno Doiron, Wenchao Hu, Ralph A DeFronzo
Diabetes Care|March 5, 2002
Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetesYoshinori Miyazaki, Masafumi Matsuda, Ralph A DeFronzo
Expert Opinion on Pharmacotherapy|June 27, 2013
Dapagliflozin for the treatment of type 2 diabetesMuhammad A Abdul-Ghani, Ralph A DeFronzo
The Journal of Clinical Endocrinology and Metabolism|June 24, 2011
Preservation of β-cell function: the key to diabetes preventionRalph A DeFronzo, Muhammad A Abdul-Ghani
Journal of Biomedicine & Biotechnology|May 7, 2010
Pathogenesis of insulin resistance in skeletal muscleMuhammad A Abdul-Ghani, Ralph A DeFronzo
Vascular Health and Risk Management|September 23, 2010
Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatmentCurtis Triplitt, Eugenio Cersosimo, Ralph A DeFronzo
Diabetes|January 6, 2017
Role of Adipose Tissue Insulin Resistance in the Natural History of Type 2 Diabetes: Results From the San Antonio Metabolism StudyAmalia Gastaldelli, Melania Gaggini, Ralph A DeFronzo
Diabetes, Obesity & Metabolism|October 10, 2006
AMP-activated protein kinase: Role in metabolism and therapeutic implicationsGreg Schimmack, Ralph A Defronzo, Nicolas Musi
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 11, 2008
Inhibition of renal glucose reabsorption: a novel strategy for achieving glucose control in type 2 diabetes mellitusMuhammad A Abdul-Ghani, Ralph A DeFronzo
Pageof 32

Showing results (21-30 of 313) with videos related to

Sort By:
Pageof 32
Diabetes Spectrum : a Publication of the American Diabetes Association|September 13, 2021
Sodium-Glucose Cotransporter 2 Inhibitors and the KidneyRalph A DeFronzo, Muhammad Abdul-Ghani
Current Pharmaceutical Biotechnology|December 24, 2015
Beta Cell Formation in vivo Through Cellular Networking, Integration and Processing (CNIP) in Wild Type Adult MiceBruno Doiron, Wenchao Hu, Ralph A DeFronzo
Diabetes Care|March 5, 2002
Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetesYoshinori Miyazaki, Masafumi Matsuda, Ralph A DeFronzo
Expert Opinion on Pharmacotherapy|June 27, 2013
Dapagliflozin for the treatment of type 2 diabetesMuhammad A Abdul-Ghani, Ralph A DeFronzo
The Journal of Clinical Endocrinology and Metabolism|June 24, 2011
Preservation of β-cell function: the key to diabetes preventionRalph A DeFronzo, Muhammad A Abdul-Ghani
Journal of Biomedicine & Biotechnology|May 7, 2010
Pathogenesis of insulin resistance in skeletal muscleMuhammad A Abdul-Ghani, Ralph A DeFronzo
Vascular Health and Risk Management|September 23, 2010
Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatmentCurtis Triplitt, Eugenio Cersosimo, Ralph A DeFronzo
Diabetes|January 6, 2017
Role of Adipose Tissue Insulin Resistance in the Natural History of Type 2 Diabetes: Results From the San Antonio Metabolism StudyAmalia Gastaldelli, Melania Gaggini, Ralph A DeFronzo
Diabetes, Obesity & Metabolism|October 10, 2006
AMP-activated protein kinase: Role in metabolism and therapeutic implicationsGreg Schimmack, Ralph A Defronzo, Nicolas Musi
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 11, 2008
Inhibition of renal glucose reabsorption: a novel strategy for achieving glucose control in type 2 diabetes mellitusMuhammad A Abdul-Ghani, Ralph A DeFronzo
Pageof 32